LAG3 antibody (AA 66-332)
-
- Target See all LAG3 Antibodies
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Binding Specificity
- AA 66-332
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This LAG3 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- Human LAG3 / CD223
- Purification
- Immunoaffinity purified
- Immunogen
-
Human recombinant protein fragment corresponding to amino acids 66-332 of human LAG3(NP_002277) produced in E. coli.
Type of Immunogen: Recombinant protein - Clone
- 10E7
- Isotype
- IgG2a
- Top Product
- Discover our top product LAG3 Primary Antibody
-
-
- Application Notes
- Approved: WB (1:2000)
- Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Alternative Name
- LAG3 (LAG3 Products)
- Synonyms
- CD223 antibody, LAG-3 antibody, Ly66 antibody, lymphocyte activating 3 antibody, lymphocyte-activation gene 3 antibody, LAG3 antibody, Lag3 antibody
- Background
-
Name/Gene ID: LAG3
Synonyms: LAG3, CD223 antigen, LAG-3, Protein FDC, CD223, FDC, Lymphocyte-activation gene 3 - Gene ID
- 3902
- NCBI Accession
- NP_002277
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-